3ones
Compete Blog
Xconomy San Diego
A recent Harris poll found that most Americans have never heard of a smart meter and they dont know what the smart grid is, but these new technologies are coming anyway. Weve got a lot of cleantech news, which well dispense as efficiently as possible.
Is Leap Wireless, (NASDAQ: LEAP) optimizing its operations for a possible merger? Or is it trimming its costs in an increasingly competitive market for low-cost service? The San Diego company, which pr...
show all
Xconomy San Diego
A few years ago, news articles in Business Week, Nature, and elsewhere described a veritable stampede among big pharmaceutical companies like Roche, Eli Lilly, Pfizer, and GlaxoSmithKline to work with contract research organizations in China and India.
As it turns out, some of San Diegos smallest biotech startups have been doing the same thing.
The reasonfor big and small drug development companies alikeis that the scientific capab...
show all
Things were hopping over the past week in San Diego. Get into the rhythm here.
San Diegos West Wireless Health Institute named Donald Casey chief executive officer. Casey was formerly worldwide chairman of Johnson & Johnsons comprehensive care group. The Institute was founded last year with a $45 million gift from telemarketing and communications entrepreneurs Gary and Mary West.
Tocagen raised nearly $7.8 million in a Series D round that began Fe...
show all
Xconomy San Diego
Acadia Pharmaceuticals of San Diego and its Canadian partner Biovail are continuing to move ahead with pimavanserin. The experimental drug, you might recall, failed last September in a trial testing it as a treatment for Parkinsons disease-related psychosis.
Pimavanserin is Acadias lead drug candidate, which may help explain why Acadia (NASDAQ: ACAD) and its partner arent willing to give up on it.
The companies now say they expect to meet with the ...
show all
Amid considerable speculation about a potential merger, San Diegos Leap Wireless (NASDAQ: LEAP) has trimmed about 4 percent of its workforce and closed or transferred 38 of its Cricket Communications storefronts.
Leap spokesman Greg Lund confirms that the flat-rate wireless service provider laid off a total of 180 employees nationwide on March 1 as part of a cost-cutting review, which the company did not announce. The cutbacks occurred after Leap rep...
show all
San Diegos Helix Wind (NASDAQ OTC Bulletin Board: HLXW), which makes vertical-axis wind turbines, today named Scott Weinbrandt, the president and board chairman, to replace co-founder Ian Gardner as CEO. Gardner also resigned from the companys board, along with another director, Gene Hoffman. In its statement, Helix Wind also says it also has been in discussions with an investor to complete a financing of up to $1 million to be used for general w...
show all
Xconomy San Diego
Memjet, the San Diego printer technology startup that named former Qualcomm COO Len Lauer as its CEO in January, took a step toward becoming a conventional company by naming Mark W. Legg as chief financial officer, according to a statement issued today. Legg was previously the CFO at privately held General Atomics of San Diego. Lauer is in the process of reorganizing Memjet, which was founded by Australian Kia Silverbrook and did not previo...
show all
San Diegos Fallbrook Technologies, which is developing a new and more-efficient design for a continuously variable transmission, says today it has signed an agreement with Hodyon of Austin, TX, for joint development of a new air conditioner compressor for medium and heavy-duty vehicles. Financial terms of the agreement were not disclosed. Fallbrook says its deal with Hodyon is part of its broader effort to develop its technology for ...
show all
GigaOM
Cisco has unveiled a new routing system that it claims can handle 12 times the traffic capacity of the nearest competing system. And its all about the video.
The company in a much-hyped announcement this morning introduced the CRS-3, a router that can move up to 322 terabits per second enough to download the entire printed collection of the Library of Congress in one second, Cisco said, or deliver all movies ever made in about four minutes. The router has been tested by AT&T (s t) in a successful trial of ...
show all
Compete Blog
Xconomy San Diego
Isis Pharmaceuticals (NASDAQ: ISIS), the Carlsbad, CA-based biotech company, said today it has earned a $6 million payment from Bristol-Myers Squibb for getting clearance from regulators to begin clinical trials of a new cholesterol-lowering drug. Isis and Bristol are collaborating on BMS-PCSK9Rx, as a targeted antisense therapy which seeks to lower cholesterol by hitting the target PCSK9.
Roche and Cambridge, MA-based Biogen Idec are halting development of an experimental drug for rheumatoid arthritis because of safety concerns, according a report today by Bloomberg News. The drug, ocrelizumab, was designed to hit the same protein target on cells as the hit antibody ritxumimab, (Rituxan), albeit in a form thought to be more conducive for chronic autoimmune diseases than rituximab, which was originally developed as a cancer drug. Still, ...
show all
Qualcomms chairman and CEO says the San Diego wireless company is in the drivers seat when it comes to setting the agenda for the wireless industry. Were here to tell you what that means, so you dont miss the on-ramp.
When Paul Jacobs was named to head San Diegos Qualcomm five years ago, the No. 3 son of Qualcomm founder Irwin Jacobs came across as a bit wonky. But Paul Jacobs is getting better at public speaking, as he demonstrated last week in a ...
show all
HIV has taught the pharmaceutical industry that the best way to fight an infectious virus that resists a single drug is to make a cocktail that attacks the virus in more than one way. Vertex Pharmaceuticals and its competitors are now following a similar formula with new therapies for hepatitis C.
Vertex, the Cambridge, MA-based company with operations in San Diego, offered a glimpse last week into its strategy for a two-drug combo that could signifi...
show all
Xconomy San Diego
Two San Diego biotechs, Adamis Pharmaceuticals and La Jolla Pharmaceutical, said today they have agreed to terminate their merger agreement, which was signed three months ago. The Nasdaq market also delisted La Jolla Pharmaceutical today, saying the company is operating only as a public shell with minimal assets and operations. La Jolla Pharmaceutical said that after receiving a total of only 13 percent of shareholder proxies, i...
show all
Xconomy San Diego
The La Jolla Research & Innovation Summit held yesterday at the Salk Institute was a smaller and a much more modest affair than the inaugural summit that Connect CEO Duane Roth organized last year. I have some impressions from the morning presentations:
Climatologist Dan Cayan of UCSDs Scripps Institution of Oceanography explained why multiple computerized models of climate change indicate that Southern California will become significantly hotter ...
show all
There was a flurry of San Diego life sciences news over the past week, but weve got it all sorted for you here.
Politicians sometimes complain about voter apathy, but consider the plight of San Diegos La Jolla Pharmaceutical. The biotech, which failed to develop a drug for lupus, has been unable to muster enough shareholder votes to put itself out of businessor to approve a proposed merger with Adamis Pharmaceuticals (OTCBB: ADMP). In ...
show all
